Acofide (acotiamide) - Zeria Pharma, Astellas
Real-World Effectiveness of Acotiamide for Functional Dyspepsia in a South Asian Population: A Prospective Observational Study From a Tertiary Care Centre in Pakistan (ACG 2026) - Aug 29, 2026 - Abstract #P5328; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "Mean age was 38.5 ± 13.7 years; 62.5% were male. Median dyspepsia duration was 26 months (IQR 14â72). At Week 8 (n = 86 for symptom follow-up), proportions with daily epigastric pain fell from 10.0% to 1.2%, and daily bloating from 21.0% to 3.5%." 
Clinical • Observational data • Real-world • Real-world effectiveness • Real-world evidence • CNS Disorders • Dyspepsia • Gastrointestinal Disorder
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=831151&rnd=0.4402528
 
Amanullah Abbasi; Shehzeen Dua. Bhatti
 
Aug 29, 2026
 
Prev Next